Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2015, Volume 112, Issue 10, pp. E1116 - E1125
Follicular lymphoma (FL) is incurable with conventional therapies and has a clinical course typified by multiple relapses after therapy. These tumors are...
Exome | Antigen presentation | Hierarchy | CREBBP | Lymphoma | SURVIVAL | TRANSLOCATION | antigen presentation | EPIGENETIC CONTROL | MULTIDISCIPLINARY SCIENCES | lymphoma | hierarchy | SOMATIC MUTATIONS | PATHOGENESIS | B-CELL LYMPHOMA | exome | GENE-EXPRESSION | CREB BINDING-PROTEIN | T-CELLS | EZH2 | CREB-Binding Protein - genetics | Chromatin - metabolism | Flow Cytometry | Lymphoma, Follicular - genetics | Lymphoma, Follicular - immunology | Humans | Polymerase Chain Reaction | Neoplastic Stem Cells - pathology | Histocompatibility Antigens Class II - genetics | Mutation | Antigen-Presenting Cells - immunology | Antigens | Lymphomas | Genetic aspects | Gene mutations | Observations | Health aspects | Biological Sciences | PNAS Plus
Exome | Antigen presentation | Hierarchy | CREBBP | Lymphoma | SURVIVAL | TRANSLOCATION | antigen presentation | EPIGENETIC CONTROL | MULTIDISCIPLINARY SCIENCES | lymphoma | hierarchy | SOMATIC MUTATIONS | PATHOGENESIS | B-CELL LYMPHOMA | exome | GENE-EXPRESSION | CREB BINDING-PROTEIN | T-CELLS | EZH2 | CREB-Binding Protein - genetics | Chromatin - metabolism | Flow Cytometry | Lymphoma, Follicular - genetics | Lymphoma, Follicular - immunology | Humans | Polymerase Chain Reaction | Neoplastic Stem Cells - pathology | Histocompatibility Antigens Class II - genetics | Mutation | Antigen-Presenting Cells - immunology | Antigens | Lymphomas | Genetic aspects | Gene mutations | Observations | Health aspects | Biological Sciences | PNAS Plus
Journal Article
Bioelectromagnetics, ISSN 0197-8462, 07/2019, Volume 40, Issue 5, pp. 343 - 353
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 1/2014, Volume 111, Issue 1, pp. 255 - 260
Ubiquitous expression of a resident K-RasG12V oncogene in adult mice revealed that most tissues are resistant to K-Ras oncogenic signals. Indeed, K-RasG12V...
Acinar cells | Adenocarcinoma | Pulmonary alveoli | Cell growth | Lungs | B lymphocytes | Hyperplasia | Giant cells | Adenoma | Tumors | Lung stem cells | Inflammation | Genetically engineered mouse model | Non-small cell lung cancer | non-small cell lung cancer | ONCOGENE | inflammation | MULTIDISCIPLINARY SCIENCES | PANCREATITIS | INDUCTION | EXPRESSION | genetically engineered mouse model | lung stem cells | Cell Proliferation | Adenocarcinoma of Lung | Lung Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | ras Proteins - metabolism | Gene Expression Profiling | Stem Cells - cytology | Lung - cytology | Adenocarcinoma - metabolism | Flow Cytometry | Pulmonary Alveoli - metabolism | Adenocarcinoma - genetics | Oncogenes | Lung Neoplasms - genetics | Bronchioles - metabolism | Promoter Regions, Genetic | Signal Transduction | Cell Separation | Carcinoma, Non-Small-Cell Lung - metabolism | Mice, Transgenic | Animals | Cell Transformation, Neoplastic | Alleles | Mice | Adenoviridae - metabolism | Genes, ras | Cell interaction | Lung cancer | Oncology, Experimental | Cancer cells | Physiological aspects | Research | Cancer | Biological Sciences
Acinar cells | Adenocarcinoma | Pulmonary alveoli | Cell growth | Lungs | B lymphocytes | Hyperplasia | Giant cells | Adenoma | Tumors | Lung stem cells | Inflammation | Genetically engineered mouse model | Non-small cell lung cancer | non-small cell lung cancer | ONCOGENE | inflammation | MULTIDISCIPLINARY SCIENCES | PANCREATITIS | INDUCTION | EXPRESSION | genetically engineered mouse model | lung stem cells | Cell Proliferation | Adenocarcinoma of Lung | Lung Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | ras Proteins - metabolism | Gene Expression Profiling | Stem Cells - cytology | Lung - cytology | Adenocarcinoma - metabolism | Flow Cytometry | Pulmonary Alveoli - metabolism | Adenocarcinoma - genetics | Oncogenes | Lung Neoplasms - genetics | Bronchioles - metabolism | Promoter Regions, Genetic | Signal Transduction | Cell Separation | Carcinoma, Non-Small-Cell Lung - metabolism | Mice, Transgenic | Animals | Cell Transformation, Neoplastic | Alleles | Mice | Adenoviridae - metabolism | Genes, ras | Cell interaction | Lung cancer | Oncology, Experimental | Cancer cells | Physiological aspects | Research | Cancer | Biological Sciences
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1333 - 1333
Abstract Introduction: Since the implementation of next generation sequencing techniques, inherited mutations in malignancy-associated susceptibility genes...
Journal Article
The EMBO Journal, ISSN 0261-4189, 05/2013, Volume 32, Issue 11, pp. 1502 - 1513
Tumour‐associated oncogenes induce unscheduled proliferation as well as genomic and chromosomal instability. According to current models, therapeutic...
oncogenes | cancer therapy | tumoural reprogramming | cancer stem cell | mouse model | Cancer stem cell | INITIATING CELLS | BLADDER-CARCINOMA ONCOGENE | HEMATOPOIETIC STEM/PROGENITOR CELLS | STEM-CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | BCR-ABL | C-MYC | SELF-RENEWAL | CHRONIC MYELOID-LEUKEMIA | CELL BIOLOGY | PRIMARY BIOASSAY | TRANSFORMING GENE | Oncogenes - genetics | Cell Proliferation | Genetic Association Studies | Humans | Neoplastic Stem Cells | Oncogenes - physiology | Cell Biology | Neoplasms - therapy | Animals | Neoplasms - genetics | Cell Transformation, Neoplastic - genetics | Models, Biological | Mice | Mutation | Cell Transformation, Neoplastic - pathology | Neoplasms - pathology | Chromosomal Instability | Genomics | Tumors | Cancer | Review
oncogenes | cancer therapy | tumoural reprogramming | cancer stem cell | mouse model | Cancer stem cell | INITIATING CELLS | BLADDER-CARCINOMA ONCOGENE | HEMATOPOIETIC STEM/PROGENITOR CELLS | STEM-CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | BCR-ABL | C-MYC | SELF-RENEWAL | CHRONIC MYELOID-LEUKEMIA | CELL BIOLOGY | PRIMARY BIOASSAY | TRANSFORMING GENE | Oncogenes - genetics | Cell Proliferation | Genetic Association Studies | Humans | Neoplastic Stem Cells | Oncogenes - physiology | Cell Biology | Neoplasms - therapy | Animals | Neoplasms - genetics | Cell Transformation, Neoplastic - genetics | Models, Biological | Mice | Mutation | Cell Transformation, Neoplastic - pathology | Neoplasms - pathology | Chromosomal Instability | Genomics | Tumors | Cancer | Review
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 01/2014, Volume 111, Issue 1, p. 255
Ubiquitous expression of a resident K-Ras^sup G12V^ oncogene in adult mice revealed that most tissues are resistant to K-Ras oncogenic signals. Indeed,...
Lung cancer | Gene expression | Cells
Lung cancer | Gene expression | Cells
Journal Article
Cell Cycle, ISSN 1538-4101, 06/2014, Volume 13, Issue 12, pp. 1831 - 1832
Journal Article
Cancer Research, ISSN 0008-5472, 05/2018, Volume 78, Issue 10, pp. 2669 - 2679
Journal Article
Cell Cycle, ISSN 1538-4101, 04/2012, Volume 11, Issue 8, pp. 1479 - 1480
Comment on: Vicente-Dueñas C, et al. Oncotarget 2012; Epub ahead of print; PMID:22408137.
mouse models | cancer stem cells (CSC) | stem cells | cancer | drug discovery | telomerase inhibitors | Binding | Proteins | Landes | Calcium | Bioscience | Biology | Cell | Cycle | Cancer | Organogenesis | CELL BIOLOGY | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Promoter Regions, Genetic | Membrane Proteins - genetics | Humans | Antigens, Ly - genetics | Fusion Proteins, bcr-abl - genetics | Animals | Cell Transformation, Neoplastic | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Telomerase - metabolism | Mice | Neoplastic Stem Cells - enzymology | Fusion Proteins, bcr-abl - metabolism | Disease Models, Animal
mouse models | cancer stem cells (CSC) | stem cells | cancer | drug discovery | telomerase inhibitors | Binding | Proteins | Landes | Calcium | Bioscience | Biology | Cell | Cycle | Cancer | Organogenesis | CELL BIOLOGY | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Promoter Regions, Genetic | Membrane Proteins - genetics | Humans | Antigens, Ly - genetics | Fusion Proteins, bcr-abl - genetics | Animals | Cell Transformation, Neoplastic | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Telomerase - metabolism | Mice | Neoplastic Stem Cells - enzymology | Fusion Proteins, bcr-abl - metabolism | Disease Models, Animal
Journal Article
Annual Review of Genetics, ISSN 0066-4197, 2007, Volume 41, Issue 1, pp. 41 - 61
Elucidation of the molecular mechanisms that underlie disease development is still a tremendous challenge for basic science, and a prerequisite to the...
Biomarkers | Experimental therapeutics and translational oncology | Stem cell niche | Cancer stem cells | Mouse models | Stem cells | mouse models | stem cells | stem cell niche | biomarkers | E-CADHERIN EXPRESSION | C-KIT | EPITHELIAL-MESENCHYMAL TRANSITIONS | GENETICS & HEREDITY | GENE-EXPRESSION | STEM-CELL FACTOR | TYROSINE KINASE RECEPTOR | cancer stem cells | experimental therapeutics and translational oncology | HUMAN BREAST CELLS | GROWTH-FACTOR | NEURAL CREST | SLUG REPRESSOR PROTEIN | Neoplasms, Experimental - pathology | Transcription Factors - physiology | Zinc Fingers | Animals | Neoplasms, Experimental - genetics | Mice | Transcription Factors - genetics | Neoplasms, Experimental - physiopathology | Snail Family Transcription Factors
Biomarkers | Experimental therapeutics and translational oncology | Stem cell niche | Cancer stem cells | Mouse models | Stem cells | mouse models | stem cells | stem cell niche | biomarkers | E-CADHERIN EXPRESSION | C-KIT | EPITHELIAL-MESENCHYMAL TRANSITIONS | GENETICS & HEREDITY | GENE-EXPRESSION | STEM-CELL FACTOR | TYROSINE KINASE RECEPTOR | cancer stem cells | experimental therapeutics and translational oncology | HUMAN BREAST CELLS | GROWTH-FACTOR | NEURAL CREST | SLUG REPRESSOR PROTEIN | Neoplasms, Experimental - pathology | Transcription Factors - physiology | Zinc Fingers | Animals | Neoplasms, Experimental - genetics | Mice | Transcription Factors - genetics | Neoplasms, Experimental - physiopathology | Snail Family Transcription Factors
Journal Article
Cancer Discovery, ISSN 2159-8274, 12/2015, Volume 5, Issue 12, pp. 1328 - 1343
Earlier in the past century, infections were regarded as the most likely cause of childhood B-cell precursor acute lymphoblastic leukemia (pB-ALL). However,...
ACTIVATION | ONCOLOGY | GENE-EXPRESSION | MECHANISMS | PAX5 | DIFFERENTIATION | NORMALIZATION | CHILDHOOD | LINEAGE | CANCER | JAK3 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - etiology | Interleukin-7 - pharmacology | Male | Gene Expression Profiling | Exome | Janus Kinase 3 - antagonists & inhibitors | STAT5 Transcription Factor - genetics | Receptors, Interleukin-7 - genetics | Bone Marrow Transplantation | Female | Interleukin-7 - metabolism | Disease Models, Animal | Disease Susceptibility | PAX5 Transcription Factor - genetics | Genotype | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Virus Integration | Mice, Knockout | Host-Pathogen Interactions | Drug Resistance, Neoplasm - genetics | Phenotype | Animals | Cell Transformation, Neoplastic | Janus Kinase 3 - genetics | Cell Line, Tumor | High-Throughput Nucleotide Sequencing | Mice | Protein Kinase Inhibitors - pharmacology | Mutation | Cluster Analysis
ACTIVATION | ONCOLOGY | GENE-EXPRESSION | MECHANISMS | PAX5 | DIFFERENTIATION | NORMALIZATION | CHILDHOOD | LINEAGE | CANCER | JAK3 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - etiology | Interleukin-7 - pharmacology | Male | Gene Expression Profiling | Exome | Janus Kinase 3 - antagonists & inhibitors | STAT5 Transcription Factor - genetics | Receptors, Interleukin-7 - genetics | Bone Marrow Transplantation | Female | Interleukin-7 - metabolism | Disease Models, Animal | Disease Susceptibility | PAX5 Transcription Factor - genetics | Genotype | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Virus Integration | Mice, Knockout | Host-Pathogen Interactions | Drug Resistance, Neoplasm - genetics | Phenotype | Animals | Cell Transformation, Neoplastic | Janus Kinase 3 - genetics | Cell Line, Tumor | High-Throughput Nucleotide Sequencing | Mice | Protein Kinase Inhibitors - pharmacology | Mutation | Cluster Analysis
Journal Article
Blood, ISSN 0006-4971, 05/2017, Volume 129, Issue 19, pp. 2645 - 2656
CREBBP is targeted by inactivating mutations in follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). Here, we provide evidence from transgenic...
B-CELL LYMPHOMA | ANALYSES REVEAL | MYC | P300 | GENE-EXPRESSION | GENOME-WIDE | FOLLICULAR LYMPHOMA | BINDING PROTEIN | HEMATOLOGY | HISTONE ACETYLATION | SOMATIC MUTATIONS | Lymphoma, Large B-Cell, Diffuse - pathology | Epigenesis, Genetic | Humans | Gene Expression Regulation, Neoplastic | Mice, Transgenic | CREB-Binding Protein - genetics | Animals | Lymphoma, Follicular - genetics | Gene Deletion | Mice | B-Lymphocytes - pathology | Mutation | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Lymphoid Neoplasia
B-CELL LYMPHOMA | ANALYSES REVEAL | MYC | P300 | GENE-EXPRESSION | GENOME-WIDE | FOLLICULAR LYMPHOMA | BINDING PROTEIN | HEMATOLOGY | HISTONE ACETYLATION | SOMATIC MUTATIONS | Lymphoma, Large B-Cell, Diffuse - pathology | Epigenesis, Genetic | Humans | Gene Expression Regulation, Neoplastic | Mice, Transgenic | CREB-Binding Protein - genetics | Animals | Lymphoma, Follicular - genetics | Gene Deletion | Mice | B-Lymphocytes - pathology | Mutation | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Lymphoid Neoplasia
Journal Article
Nature Communications, ISSN 2041-1723, 06/2014, Volume 5, Issue 1, p. 3904
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma and can be separated into two subtypes based upon molecular features with similarities to...
MOLECULAR SUBTYPES | INTEGRATIVE ANALYSIS REVEALS | STEM-CELLS | DNA METHYLATION | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | CHRONIC LYMPHOCYTIC-LEUKEMIA | NON-HODGKIN-LYMPHOMA | MYELOID-LEUKEMIA | SOMATIC MUTATION | COPY-NUMBER ALTERATION | Doxorubicin - therapeutic use | Prognosis | Epigenesis, Genetic | Humans | Gene Expression Regulation, Neoplastic | Male | Lymphoma, Large B-Cell, Diffuse - metabolism | Cyclophosphamide - therapeutic use | DNA Copy Number Variations | DNA-Binding Proteins - metabolism | DNA Methylation | Female | B-Lymphocytes - metabolism | Lymphoma, Large B-Cell, Diffuse - drug therapy | Mice, Transgenic | Hematopoietic Stem Cells - metabolism | DNA-Binding Proteins - genetics | Phenotype | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Proto-Oncogene Proteins c-bcl-6
MOLECULAR SUBTYPES | INTEGRATIVE ANALYSIS REVEALS | STEM-CELLS | DNA METHYLATION | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | CHRONIC LYMPHOCYTIC-LEUKEMIA | NON-HODGKIN-LYMPHOMA | MYELOID-LEUKEMIA | SOMATIC MUTATION | COPY-NUMBER ALTERATION | Doxorubicin - therapeutic use | Prognosis | Epigenesis, Genetic | Humans | Gene Expression Regulation, Neoplastic | Male | Lymphoma, Large B-Cell, Diffuse - metabolism | Cyclophosphamide - therapeutic use | DNA Copy Number Variations | DNA-Binding Proteins - metabolism | DNA Methylation | Female | B-Lymphocytes - metabolism | Lymphoma, Large B-Cell, Diffuse - drug therapy | Mice, Transgenic | Hematopoietic Stem Cells - metabolism | DNA-Binding Proteins - genetics | Phenotype | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Proto-Oncogene Proteins c-bcl-6
Journal Article
Leukemia, ISSN 0887-6924, 01/2019, Volume 33, Issue 1, pp. 249 - 278
Journal Article
Seminars in Cancer Biology, ISSN 1044-579X, 2014, Volume 32, pp. 3 - 9
Abstract Cancer is a clonal malignant disease originated in a single cell and characterized by the accumulation of partially differentiated cells that are...
Hematology, Oncology and Palliative Medicine | Cancer stem cell | Mouse model | Oncogenes | Tumoral reprogramming | Stem cells | BLADDER-CARCINOMA ONCOGENE | HEMATOPOIETIC STEM/PROGENITOR CELLS | RAS | PERSISTENCE | HARVEY | KINASE | CHRONIC MYELOID-LEUKEMIA | ONCOLOGY | PRIMARY BIOASSAY | TRANSFORMING GENE | EXPRESSION | Cell Differentiation - genetics | Oncogenes - genetics | Neoplasms - therapy | Animals | Neoplasms - genetics | Cell Transformation, Neoplastic - genetics | Models, Biological | Humans | Mice | Neoplastic Stem Cells | Cellular Reprogramming - genetics | Disease Models, Animal | Antimitotic agents | Care and treatment | Automobile driving | Analysis | Antineoplastic agents | Health aspects | Cancer | Motor vehicle driving
Hematology, Oncology and Palliative Medicine | Cancer stem cell | Mouse model | Oncogenes | Tumoral reprogramming | Stem cells | BLADDER-CARCINOMA ONCOGENE | HEMATOPOIETIC STEM/PROGENITOR CELLS | RAS | PERSISTENCE | HARVEY | KINASE | CHRONIC MYELOID-LEUKEMIA | ONCOLOGY | PRIMARY BIOASSAY | TRANSFORMING GENE | EXPRESSION | Cell Differentiation - genetics | Oncogenes - genetics | Neoplasms - therapy | Animals | Neoplasms - genetics | Cell Transformation, Neoplastic - genetics | Models, Biological | Humans | Mice | Neoplastic Stem Cells | Cellular Reprogramming - genetics | Disease Models, Animal | Antimitotic agents | Care and treatment | Automobile driving | Analysis | Antineoplastic agents | Health aspects | Cancer | Motor vehicle driving
Journal Article
Cancer Research, ISSN 0008-5472, 08/2017, Volume 77, Issue 16, pp. 4365 - 4377
ETV6-RUNX1 is associated with the most common subtype of childhood leukemia. As few ETV6-RUNX1 carriers develop precursor B-cell acute lymphocytic leukemia...
RECOMBINATION | READ ALIGNMENT | TEL/AML1 | SPECIFICITY | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | TEL-AML1 | MECHANISMS | NORMALIZATION | EXPRESSION | BURROWS-WHEELER TRANSFORM | Oncogene Proteins, Fusion - metabolism | Core Binding Factor Alpha 2 Subunit - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Mice, Inbred C57BL | Oncogene Proteins, Fusion - biosynthesis | Male | Mice, Transgenic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - microbiology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Histone Demethylases - metabolism | Animals | Core Binding Factor Alpha 2 Subunit - biosynthesis | Oncogene Proteins, Fusion - genetics | Mice, Inbred CBA | Mice | Core Binding Factor Alpha 2 Subunit - genetics | Disease Models, Animal | Hematopoietic Stem Cells | Recombination | Leukemia | Biological evolution | Stem cell transplantation | Runx1 protein | Infections | Exposure | Lymphatic leukemia | Alterations | RAG2 protein | Lymphocytes B | Lysine | Precursors | RAG1 protein | Stem cells | Children | Mutation | Cancer
RECOMBINATION | READ ALIGNMENT | TEL/AML1 | SPECIFICITY | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | TEL-AML1 | MECHANISMS | NORMALIZATION | EXPRESSION | BURROWS-WHEELER TRANSFORM | Oncogene Proteins, Fusion - metabolism | Core Binding Factor Alpha 2 Subunit - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Mice, Inbred C57BL | Oncogene Proteins, Fusion - biosynthesis | Male | Mice, Transgenic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - microbiology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Histone Demethylases - metabolism | Animals | Core Binding Factor Alpha 2 Subunit - biosynthesis | Oncogene Proteins, Fusion - genetics | Mice, Inbred CBA | Mice | Core Binding Factor Alpha 2 Subunit - genetics | Disease Models, Animal | Hematopoietic Stem Cells | Recombination | Leukemia | Biological evolution | Stem cell transplantation | Runx1 protein | Infections | Exposure | Lymphatic leukemia | Alterations | RAG2 protein | Lymphocytes B | Lysine | Precursors | RAG1 protein | Stem cells | Children | Mutation | Cancer
Journal Article
Bioelectromagnetics, ISSN 0197-8462, 07/2019, Volume 40, Issue 5, pp. 343 - 353
Exposure to extremely low‐frequency magnetic fields (ELF‐MFs) has been classified by the International Agency for Research on Cancer (IARC) as “possibly...
ARIMMORA project | magnetic field | cancer susceptibility | exposure | FUSION | FREQUENCY MAGNETIC-FIELDS | MECHANISMS | CHILDREN | PRENATAL ORIGIN | TEL/AML1 | BIOPHYSICS | DISEASE | BIOLOGY | INFECTION | TEL-AML1 | Animal experimentation | Oncology, Experimental | Disease susceptibility | Research | Children | Acute lymphocytic leukemia | Magnetic fields | Cancer | Diseases | Flow cytometry | Animal models | Statistical analysis | Acute lymphatic leukemia | Leukemia | Runx1 protein | Exposure | Malignancy | Lymphatic leukemia | Carcinogens | Ataxin | Lymphocytes B | Etiology | Magnetic permeability | Peripheral blood | Mice | Fusion protein | Index Medicus
ARIMMORA project | magnetic field | cancer susceptibility | exposure | FUSION | FREQUENCY MAGNETIC-FIELDS | MECHANISMS | CHILDREN | PRENATAL ORIGIN | TEL/AML1 | BIOPHYSICS | DISEASE | BIOLOGY | INFECTION | TEL-AML1 | Animal experimentation | Oncology, Experimental | Disease susceptibility | Research | Children | Acute lymphocytic leukemia | Magnetic fields | Cancer | Diseases | Flow cytometry | Animal models | Statistical analysis | Acute lymphatic leukemia | Leukemia | Runx1 protein | Exposure | Malignancy | Lymphatic leukemia | Carcinogens | Ataxin | Lymphocytes B | Etiology | Magnetic permeability | Peripheral blood | Mice | Fusion protein | Index Medicus
Journal Article